Literature DB >> 3341219

Left ventricular filling in sickle cell anemia.

I C Balfour1, W Covitz, F W Arensman, C Eubig, M Garrido, C Jones.   

Abstract

M-mode echocardiography was performed on 11 normal black subjects and 38 patients with sickle cell anemia while they were at rest to evaluate their left ventricular (LV) systolic and diastolic function. The patients with sickle cell anemia were also evaluated by radionuclide exercise tests and, based on their ejection fraction (EF) response, were separated into 2 groups: a group with a normal EF response to exercise (73 +/- 9%, mean +/- standard deviation) and a group with an abnormal EF response to exercise (53 +/- 9%). Computer-assisted analysis of the M-mode echocardiograms identified abnormalities of diastolic function (impaired left ventricular filling) in patients with sickle cell anemia compared with the normal subjects. The abnormal EF response group had significantly more impaired diastolic function and did less exercise than the normal EF response group. Both groups of patients had a decrease in left ventricular end-diastolic volume during exercise. The patients with sickle cell anemia had abnormalities of systolic and diastolic function on echocardiographic and radionuclide testing. The abnormalities in diastolic and systolic function assumed greater significance at the increased heart rates associated with exercise, accounting for the decrease in left ventricular end-diastolic volume and the abnormal EF response, and contributed to exercise intolerance in patients with sickle cell anemia.

Entities:  

Mesh:

Year:  1988        PMID: 3341219     DOI: 10.1016/0002-9149(88)90952-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease.

Authors:  Vandana Sachdev; Roberto F Machado; Yukitaka Shizukuda; Yesoda N Rao; Stanislav Sidenko; Inez Ernst; Marilyn St Peter; Wynona A Coles; Douglas R Rosing; William C Blackwelder; Oswaldo Castro; Gregory J Kato; Mark T Gladwin
Journal:  J Am Coll Cardiol       Date:  2007-01-16       Impact factor: 24.094

2.  Echocardiographic evaluation of left ventricular diastolic and systolic function in Saudi patients with sickle cell disease.

Authors:  Mohammed Fakhry Abdul-Mohsen
Journal:  J Saudi Heart Assoc       Date:  2012-06-12

Review 3.  Cardiovascular abnormalities in sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev
Journal:  J Am Coll Cardiol       Date:  2012-03-27       Impact factor: 24.094

4.  Systolic and diastolic function in middle aged patients with sickle beta thalassaemia. An echocardiographic study.

Authors:  I Moyssakis; R Tzanetea; P Tsaftaridis; I Rombos; D P Papadopoulos; V Kalotychou; A Aessopos
Journal:  Postgrad Med J       Date:  2005-11       Impact factor: 2.401

5.  Myocardial infarction in sickle cell disease.

Authors:  C R Martin; C S Johnson; C Cobb; D Tatter; L J Haywood
Journal:  J Natl Med Assoc       Date:  1996-07       Impact factor: 1.798

6.  Genome-wide meta-analysis of systolic blood pressure in children with sickle cell disease.

Authors:  Pallav Bhatnagar; Emily Barron-Casella; Christopher J Bean; Jacqueline N Milton; Clinton T Baldwin; Martin H Steinberg; Michael Debaun; James F Casella; Dan E Arking
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

7.  Electrocardiographic Study in Adult Homozygous Sickle Cell Disease Patients in Lagos, Nigeria.

Authors:  Adedoyin Dosunmu; Akinsegun Akinbami; Ebele Uche; Adewumi Adediran; Sarah John-Olabode
Journal:  J Trop Med       Date:  2016-09-21

8.  Left ventricular function and cardiac valvar annular dimensions among children with sickle cell anemia compared to those with hemoglobin AA type in Enugu, Nigeria.

Authors:  Josephat M Chinawa; Awore T Chinawa; Edmund N Ossai; Bartholomew F Chukwu; Ikenna K Ndu; Isaac N Asinobi
Journal:  Malawi Med J       Date:  2021-06       Impact factor: 0.875

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.